In a separate study about the outcome of patients, the results show that the expression levels of PIWIL1, PIWIL2, and PIWIL4 were positively associated with advanced clinical staging, and low expression of them reduced overall survival in ccRCC [31]. This evidence concerns the gene PIWIL4 and nonpapillary renal cell carcinoma.